Affärssegment Becton, Dickinson and Company Deutsche Boerse AG
Aktier
BOX
US0758871091
Medicinsk utrustning, förnödenheter & distribution
|
Marknaden stängd -
Deutsche Boerse AG
16.44.05 2026-09-29
|
5-dagars förändring | Förändring 1 jan. | ||
| 159,00 EUR | −0,66 % |
|
+1,40 % | −3,96 % |
| 09-21 | Becton, Dickinson utser Arthur Hu till ny it- och digitalchef | MT |
| 09-21 | Becton, Dickinson and Company utser Arthur Hu till ny IT- och digitaliseringschef | CI |
Försäljning 2025 per affärssegment
Försäljning 2025 efter Geografi
Historisk fördelning av intäkter per affärssegment
Operating Income: Fördelning efter verksamhetssegment
Historik över geografisk fördelning av omsättning
| Skatteperiod: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Equipment | ||||||||||
BD Medical (Excl. of BD Interventional) | 9,48 md | 8,84 md | 9,5 md | 10,07 md | 11,46 md | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | −777 mn | −602 mn | −563 mn | −438 mn | −469 mn | |||||
D&A | 1,14 md | 1,14 md | 1,2 md | 1,22 md | 1,39 md | |||||
Operating Income | 2,58 md | 2,22 md | 1,97 md | 2,74 md | 4,14 md | |||||
| - | - | - | - | 11,46 md | ||||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
BD Interventional | 4,24 md | 4,46 md | 4,74 md | 4,98 md | 5,22 md | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | −125 mn | −130 mn | −138 mn | −127 mn | −142 mn | |||||
D&A | 769 mn | 789 mn | 799 mn | 786 mn | 795 mn | |||||
Operating Income | 933 mn | 1,08 md | 1,22 md | 1,42 md | 2,25 md | |||||
| - | - | - | - | 5,22 md | ||||||
Life Sciences Tools and Services | ||||||||||
BD Life Sciences | 6,53 md | 5,56 md | 5,13 md | 5,19 md | 5,17 md | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | −297 mn | −213 mn | −139 mn | −114 mn | −121 mn | |||||
D&A | 352 mn | 283 mn | 277 mn | 272 mn | 261 mn | |||||
Operating Income | 2,39 md | 1,71 md | 1,58 md | 1,6 md | 1,64 md | |||||
| - | - | - | - | 5,17 md | ||||||
Other | - | - | - | −67 mn | - | |||||
CAPEX | −32 mn | −28 mn | −35 mn | −46 mn | −28 mn | |||||
D&A | 12 mn | 13 mn | 13 mn | 13 mn | 14 mn | |||||
Total Assets | - | - | - | - | - | |||||
Medical Consumables | ||||||||||
Medical | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - |
| Skatteperiod: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 10,97 md | 10,72 md | 11,11 md | 11,66 md | 12,79 md | |||||
Total Assets | 36,04 md | 36,62 md | 35,73 md | 35,53 md | 34,78 md | |||||
Total Assets | 465 mn | 442 mn | 418 mn | 459 mn | 500 mn | |||||
Europe, The Middle East and Africa (EMEA) | 4,75 md | 4,04 md | 4,24 md | 4,4 md | 4,73 md | |||||
Total Assets | 6 md | 5,13 md | 5,32 md | 6,71 md | 6,76 md | |||||
Greater Asia | 3,27 md | 3,05 md | 2,91 md | 2,91 md | 3,09 md | |||||
Total Assets | 1,66 md | 1,53 md | 1,52 md | 1,58 md | 1,59 md | |||||
| - | - | - | - | 4,73 md | ||||||
Other | 1,26 md | 1,06 md | 1,1 md | 1,21 md | 1,23 md | |||||
Total Assets | 860 mn | 1,08 md | 1,12 md | 2,55 md | 2,45 md | |||||
| - | - | - | - | 3,09 md | ||||||
Europe | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
| - | - | - | - | 1,23 md | ||||||
| - | - | - | - | 12,79 md |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
